Updated: March 27, 2026
Balmex Ointment Shortage: What Providers and Prescribers Need to Know in 2026
Author
Peter Daggett

Summarize with AI
A provider briefing on Balmex Ointment availability in 2026, including supply status, alternatives, cost data, and patient communication tools.
Provider Briefing: Balmex Ointment Availability in 2026
If your patients are reporting difficulty finding Balmex Ointment — the Zinc Oxide-based skin protectant commonly recommended for diaper rash and skin irritation — you're hearing a legitimate concern. While Balmex is not in an official shortage, its retail availability has become inconsistent in many markets.
This briefing provides the clinical and logistical context you need to advise patients, recommend alternatives, and streamline your practice's approach to OTC skin protectant recommendations.
Current Supply Status
As of March 2026, Balmex Ointment is not listed on the FDA Drug Shortage Database or the ASHP Drug Shortages Resource Center. The product remains in active production by Crossingwell Consumer Health, which acquired the Balmex brand from Chattem (Sanofi).
However, inconsistent retail availability has been reported across multiple regions. This is driven by:
- Retail planogram changes: Some retailers have reduced shelf space for Balmex in favor of higher-volume competitors
- Distribution network restructuring following the manufacturer transition from Chattem to Crossingwell
- Shift to online purchasing reducing in-store inventory allocations
- Regional variation in distributor relationships and stock levels
The bottom line: supply exists, but patients may not find it at their usual pharmacy.
Timeline of Events
- Historical: Balmex has been a pediatrician-recommended diaper rash brand for decades, originally manufactured by Chattem (acquired by Sanofi)
- Transition period: Crossingwell Consumer Health took over the Balmex brand, leading to distribution adjustments
- 2025-2026: Increased reports from patients of difficulty finding Balmex at brick-and-mortar retailers, though the product remains available online and through select pharmacies
Prescribing Implications
Balmex is an OTC product and does not require a prescription. However, many providers recommend specific products by name during patient counseling. Consider the following adjustments:
Recommend by Active Ingredient, Not Brand
Instead of recommending "Balmex" specifically, consider recommending "a Zinc Oxide-based diaper rash cream" and providing 2-3 brand options. This gives patients flexibility to purchase whatever is available.
Specify Zinc Oxide Concentration
Zinc Oxide skin protectants range from approximately 10% to 40%. For clinical context:
- 10-13% (Balmex, Desitin Daily Defense): Prevention and mild rash
- 16% (Boudreaux's Butt Paste): Mild to moderate rash
- 40% (Desitin Maximum Strength, Boudreaux's Max Strength): Moderate to severe rash
Matching concentration to rash severity helps patients select an appropriate alternative if their preferred brand is unavailable.
Document OTC Recommendations
Even though Balmex doesn't require a prescription, documenting your OTC recommendation in the chart helps ensure continuity of care and supports patient education at follow-up visits.
Availability Picture
The following table summarizes current availability channels:
- Major pharmacy chains (CVS, Walgreens, Rite Aid): Inconsistent — varies by location
- Big-box retailers (Walmart, Target): Available at some locations; more reliably available online
- Independent pharmacies: May carry or can special-order from distributors
- Online (Amazon, balmex.com, Walmart.com): Generally in stock
- Hospital/institutional supply: Generic Zinc Oxide preparations typically available through institutional formularies
Cost and Access Considerations
As an OTC product, Balmex is not covered by most insurance plans but may be reimbursable through FSA/HSA accounts. Current pricing:
- Balmex Complete Protection (4 oz): $8 to $14
- Balmex Complete Protection (16 oz jar): Up to $21
- Desitin Maximum Strength (4 oz): $7 to $14
- Boudreaux's Butt Paste (4 oz): $8 to $13
- Triple Paste (2 oz): $10 to $18
- Generic Zinc Oxide cream: $4 to $8
For patients facing financial hardship, generic Zinc Oxide creams provide equivalent protection at significantly lower cost. Community diaper banks may also provide skin care products to families in need.
Direct patients to our savings guide: How to Save Money on Balmex Ointment.
Tools and Resources for Your Practice
Medfinder for Providers
Medfinder allows providers to help patients locate OTC and prescription products in stock at nearby pharmacies. Consider recommending Medfinder to patients who report difficulty finding products, or use it during appointments to identify availability in the patient's area.
Patient Education
Consider sharing these resources with patients and families:
- What Is Balmex Ointment? — Overview for patients
- Alternatives to Balmex Ointment — Helps patients find substitutes
- How to Find Balmex Ointment in Stock — Step-by-step guide
Clinical Decision Support
When a patient presents with diaper rash or skin irritation and asks about Balmex specifically:
- Confirm the clinical indication and severity
- Recommend an appropriate Zinc Oxide concentration range
- Provide 2-3 brand alternatives at that concentration
- Direct to Medfinder for availability checking
- Document the recommendation in the patient chart
Looking Ahead
The OTC skin protectant market is stable and competitive, which means patients generally have multiple options even when a specific brand is temporarily unavailable. Key trends to watch:
- Continued manufacturer consolidation in the OTC space may lead to further brand transitions
- Growing demand for natural and organic formulations is expanding the product landscape
- Telehealth adoption makes it easier for patients to get skin care recommendations without in-office visits
- Digital tools like Medfinder are reducing the friction of locating specific OTC products
Final Thoughts
Balmex Ointment remains a safe and effective OTC skin protectant, but its inconsistent retail availability warrants adjusting how you recommend it. By counseling patients on active ingredients rather than specific brands, providing alternative options, and leveraging tools like Medfinder, you can ensure your patients get the care they need without unnecessary frustration.
For a step-by-step practice guide, see our companion post: How to Help Your Patients Find Balmex Ointment in Stock.
Frequently Asked Questions
No. As of March 2026, Balmex Ointment is not listed on the FDA Drug Shortage Database or ASHP shortage list. However, retail availability is inconsistent due to distribution changes, manufacturer transitions, and retailer stocking decisions.
For prevention and mild rash, 10-13% Zinc Oxide products (Balmex, Desitin Daily Defense) are appropriate. For moderate rash, 16% (Boudreaux's Butt Paste). For severe rash, 40% (Desitin Maximum Strength). Matching concentration to severity gives patients the most effective treatment.
Recommend by active ingredient rather than brand. Effective Zinc Oxide alternatives include Desitin (13% or 40%), Boudreaux's Butt Paste (16% or 40%), Triple Paste (12.8%), and generic Zinc Oxide creams ($4-$8). A+D Original Ointment provides a petrolatum-based alternative.
Direct patients to Medfinder (medfinder.com/providers) for real-time pharmacy availability, suggest online ordering from balmex.com or Amazon, and recommend independent pharmacies that can special-order from distributors. Providing 2-3 brand alternatives also reduces patient frustration.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Ovide also looked for:
More about Ovide
32,326 have already found their meds with Medfinder.
Start your search today.





